Wisconsin political, business and science leaders who have pushed the state’s nascent biotech industry reacted with dismay Wednesday to a vote by the Assembly Tuesday night that would bar companies doing research on new stem cell lines from applying for research and development tax credits.
Office of Strategic Communication